Physician profile
Travis Campbell
NPI 1740375757
$639.82
in general payments reported to CMS, 2019-2025
9 companies · $40.03 in 2025
The $40.03 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $241 · 2024: $359 · 2025: $40.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $215.17 | 2024 | Vasoview Hemopro 2 |
| Seagen INC. | $102.53 | 2023 | Tukysa, Padcev |
| Medical Device Business Services, INC. | $101.28 | 2024 | Evarrest |
| Merck Sharp & Dohme LLC | $72.84 | 2023 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $47.83 | 2023 | |
| Cvrx, INC. | $40.03 | 2025 | Barostim Neo System |
| Glaxosmithkline, LLC. | $24.20 | 2024 | Ojjaara |
| Incyte Corporation | $18.58 | 2024 | Jakafi |
| Eisai INC. | $17.36 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.